adidas AG N (ADS.DE)

Executive Summary

Adidas shares fell a further 2.96% since the 14 August report, closing at $154.20 and extending the post-Q2 earnings correction for a fourth consecutive reporting cycle. The only incremental news—a Bloomberg commentary reiterating structural China headwinds—reinforces rather than resolves the bearish narrative established after the 30 July earnings miss. With no offsetting fundamental catalyst, the stock has broken below its prior consolidation range, and the investment thesis now leans more decisively toward caution pending evidence of margin recovery and China stabilization.

Key Updates

Since the 14 August report ($158.90), Adidas shares declined 2.96% to $154.20, continuing an uninterrupted four-report decline from the $165.55 level recorded on 7 August (cumulative drawdown of approximately 6.8% over two weeks). The sole new data point is a Bloomberg Business opinion piece (10 August) asserting that Adidas has yet to recover pre-pandemic momentum in China and that reliance on heritage products and viral trends will be insufficient for a full turnaround. No new earnings, guidance, or management updates have been reported since the prior review.

Current Trend

YTD performance stands at -8.78%, with the 1-month return of -14.05% reflecting the sharp deterioration since the 30 July earnings release. The 6-month return of -2.84% is comparatively mild, indicating that most of the year's losses have been concentrated in the post-earnings period. The stock is now testing the $150–151 zone, the intraday low established on the 30 July crash (shares fell to €150.70 that session per Morningstar/Reuters), suggesting this level is becoming a key technical reference point. The prior support band of $158–162, referenced in the 7–14 August reports, has been decisively breached and now constitutes near-term resistance.

Investment Thesis

The core thesis remains centered on a bifurcated fundamental picture: robust top-line execution (FY constant-currency revenue guidance raised to 9–10%, Q2 net sales of €6.74bn, +14% ccy) versus margin compression driven by elevated World Cup marketing spend (Q2 operating profit of €574m, missing consensus of €623m). China remains a structural overhang, with market share losses to domestic brands persisting despite reported gains in the region during Q2. A pending CFO transition (Birgit Kretschmer replacing Harm Ohlmeyer at year-end) adds a leadership variable to the medium-term outlook.

Thesis Status

The thesis has weakened incrementally. Absent fresh negative catalysts beyond the reiterated China concerns, the continued 2.96% decline signals that market sentiment remains fragile and that investors are discounting the maintained ~€2.3bn operating profit guidance as insufficiently reassuring. The lack of a rebound following four consecutive negative reporting periods suggests the market is pricing in execution risk on both the China recovery and H2 margin normalization, shifting the thesis toward a "show-me" story rather than a value-recovery narrative.

Key Drivers

The primary driver since the last report is the persistence of China-related structural concerns, as highlighted in Bloomberg's 10 August commentary, which notes incomplete recovery of pre-pandemic business momentum and competitive pressure from domestic labels. This compounds the unresolved overhang from the 30 July earnings miss, where a 30% increase in marketing spend (>€200m) tied to World Cup campaigns pressured operating profit despite record revenue (Reuters, FT). The upcoming CFO transition (Morningstar) remains a background factor for medium-term execution risk.

Technical Analysis

The stock is in a confirmed downtrend, having declined in four consecutive reporting windows since 7 August. Price action shows a break below the $158–162 support zone that had held during the 7–14 August period, with the market now approaching the $150–151 level established as the post-earnings crash low on 30 July. A sustained break below $150 would open further downside with no clear technical support until levels not yet tested in the current data set. The 1-day (-1.09%) and 5-day (-3.17%) figures indicate accelerating downward momentum rather than stabilization, and the -14.05% 1-month move confirms the trend remains firmly bearish in the near term.

Bull Case

• FY currency-neutral revenue guidance raised to 9-10% from a prior high-single-digit forecast, reflecting stronger-than-expected demand: WSJ
• Record Q2 net sales of €6.74bn, up 14% at constant currency, driven by running/football products and gains in China: Financial Times
• Potential US tariff refunds of $250-300 million not yet incorporated into guidance, representing unrecognized upside: Morningstar
• Management maintained full-year operating profit guidance of approximately €2.3bn despite the Q2 shortfall, implying confidence in H2 margin recovery: Reuters
• Cumulative share price decline of over 15% since the pre-earnings level of €181 may present a valuation reset opportunity if H2 execution meets guidance: Reuters

Bear Case

• China market position remains structurally challenged, with incomplete recovery of pre-pandemic momentum and continued share losses to domestic brands: Bloomberg
• Q2 operating profit of €574 million missed consensus estimates of €623 million, and net profit of €398 million fell short of the €430 million expected: Financial Times
• Marketing expenditure rose by more than €200 million year-over-year due to World Cup campaigns, directly pressuring margins despite revenue growth: Reuters
• CFO Harm Ohlmeyer's departure at year-end introduces leadership transition risk after nearly three decades of continuity: Morningstar
• Technical downtrend has persisted across four consecutive reporting periods, with the stock breaking below the $158-162 support zone and approaching the 30 July crash low near $150-151, indicating sustained negative momentum without a fundamental catalyst.